Subhi Alaref, MD
Interventional Cardiology · Little Rock, ARNPI 1528227667
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (51.6%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Shockwave Medical, Inc accounts for 76.7% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2024 at $9,836 and has fallen 74.8% since, to $2,475 in 2025.
Across 61 payments — averaging $209.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Shockwave Medical, Inc$10K
- Abbott$2K
- AbbVie$150
- Edwards Lifesciences$113
- Angiodynamics, Inc.$99
- Medtronic$98
- plus $168 from 5 others
What the payments were for
- Speaking & faculty fees$6,60052%
- Travel & lodging$4,00231%
- Food & beverage$2,18517%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Shockwave Medical, Inc | 17 | $9,812 |
| Abbott | 26 | $2,347 |
| AbbVie | 1 | $150 |
| Edwards Lifesciences | 2 | $113 |
| Angiodynamics, Inc. | 4 | $99 |
| Medtronic | 5 | $98 |
| Inari Medical, Inc. | 1 | $55 |
| Philips North America LLC | 2 | $41 |
| Heartflow, Inc. | 1 | $32 |
| Boston Scientific | 1 | $23 |
| Cardiva Medical, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$12,787 in reported general payments places this provider in the 75th percentile of 89 interventional cardiology providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 25 | $24,322 |
| Nifedipine ErNifedipine | 19 | $754 |
| Metoprolol Succinate | 44 | $628 |
| Atorvastatin Calcium | 82 | $547 |
| Ezetimibe | 22 | $535 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 44 | $521 |
| Rosuvastatin Calcium | 32 | $486 |
| Losartan Potassium | 25 | $287 |
| Carvedilol | 39 | $276 |
| ClopidogrelClopidogrel Bisulfate | 18 | $256 |
| Hydralazine Hcl | 16 | $174 |
| Amlodipine Besylate | 24 | $136 |
| Furosemide | 22 | $89 |
| Lisinopril | 23 | $83 |
| Pravastatin Sodium | 11 | $59 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Little Rock
- Gaurav DharLittle Rock$206K
- Ernesto Ruiz-RodriguezLittle Rock$153K
- Vasili LendelLittle Rock$86K
- Thomas WattsLittle Rock$68K
- Vijay RajaLittle Rock$46K
- Stephen BroughtonLittle Rock$34K
- Mahesh Anantha NarayananLittle Rock$26K
- Aravind RaoLittle Rock$17K
- Patrick TobbiaLittle Rock$14K
- Hamza RayesLittle Rock$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.